# 119-hr-1620: Finn Sawyer Access to Cancer Testing Act

119-hr-1620, Finn Sawyer Access to Cancer Testing Act, is a 119th Congress bill sponsored by Rep. Matsui, Doris O. [D-CA-7] (D-CA); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-hr-1620
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-1620
- Congress: 119
- Title: Finn Sawyer Access to Cancer Testing Act
- Status: introduced
- Introduced: 2025-02-26
- Sponsor: Rep. Matsui, Doris O. [D-CA-7] (D-CA)
- Cosponsors: 13
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**Mandatory expansion of coverage for cancer diagnostic and laboratory tests across Medicare, Medicaid, and CHIP** would require payers to cover advanced genomic and laboratory testing for people with cancer. The bill would also create a national education and awareness program on genomic testing for clinicians and the public. - Medicare beneficiaries: The bill would cover tests like microarray analysis, DNA and RNA sequencing, whole-exome sequencing and the interpretation of those tests. Tests would be allowed at diagnosis, at recurrence, or as needed for treatment planning or monitoring, and Medicare payment would be 80% of the lesser of the actual charge or the typical lab rate, or 100% when payment is assigned. - Low-income families and children on Medicaid and CHIP: Medicaid would add these cancer diagnostic and laboratory tests as mandatory medical assistance and include them in benchmark coverage. CHIP would require coverage for targeted low-income children and, if a state elects pregnancy-related assistance, for targeted low-income pregnant women beginning January 1, 2027. - Clinicians and the public: The Secretary of Health and Human Services, in coordination with the National Human Genome Research Institute, would run an education and awareness program on genomic testing. The program would promote inclusion of molecular diagnostics education in graduate medical education and continuing medical education to improve detection and treatment planning.

## Cosponsors (13)

- Rep. Bilirakis, Gus M. [R-FL-12] (R-FL), 2025-02-26T00:00:00.000Z
- Rep. Thompson, Mike [D-CA-4] (D-CA), 2025-02-26T00:00:00.000Z
- Rep. Grijalva, Raúl M. [D-AZ-7] (D-AZ), 2025-02-26T00:00:00.000Z
- Rep. Bacon, Don [R-NE-2] (R-NE), 2025-02-26T00:00:00.000Z
- Rep. Wasserman Schultz, Debbie [D-FL-25] (D-FL), 2025-02-26T00:00:00.000Z
- Rep. Landsman, Greg [D-OH-1] (D-OH), 2025-02-26T00:00:00.000Z
- Rep. Himes, James A. [D-CT-4] (D-CT), 2025-02-26T00:00:00.000Z
- Rep. Tlaib, Rashida [D-MI-12] (D-MI), 2025-02-26T00:00:00.000Z
- Rep. Sewell, Terri A. [D-AL-7] (D-AL), 2025-02-26T00:00:00.000Z
- Rep. Davis, Donald G. [D-NC-1] (D-NC), 2025-02-26T00:00:00.000Z
- Rep. Gottheimer, Josh [D-NJ-5] (D-NJ), 2025-05-21T00:00:00.000Z
- Rep. Tonko, Paul [D-NY-20] (D-NY), 2025-11-07T00:00:00.000Z
- Rep. Pingree, Chellie [D-ME-1] (D-ME), 2025-11-10T00:00:00.000Z

## Provisions PRIA read

- Medicaid and CHIP would cover cancer tests: benefit, high. Medicaid and CHIP would have to cover cancer diagnostic and lab tests for people with a cancer diagnosis. Coverage in both programs would apply to care on or after January 1, 2027. In CHIP, pregnant women would be covered only if the State offers pregnancy-related assistance. States could get extra…
- National education on genomic testing: benefit, low. HHS, with the National Human Genome Research Institute, would run a program to teach doctors and the public about genomic testing. It would explain when testing is useful and the role of genetic counselors. It would push medical schools and continuing education to include training on molecular test…
- Medicare cancer tests covered, with limits: mixed, medium. Medicare would cover certain cancer diagnostic and lab tests for people diagnosed with cancer. The Part B deductible would not apply to these tests. Medicare would pay labs 80% of the lower of the lab charge or a Medicare-based amount, or 100% if payment is on an assignment basis. Tests that report…

## Related bills

- 119-hr-1262: Mikaela Naylon Give Kids a Chance Act
- 119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
- 119-hr-4583: Living Donor Protection Act of 2025
- 119-hr-4582: To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health conditi…
- 119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025
- 119-hr-979: AM Radio for Every Vehicle Act of 2025

## Sources
- [119-hr-1620 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/1620)

## Related
- [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262)
- [119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage A…](https://policyrisk.com/legislation/119-hr-842)
- [119-hr-4583: Living Donor Protection Act of 2025](https://policyrisk.com/legislation/119-hr-4583)
- [119-hr-4582: To amend the Family and Medical Leave Act of 1993 and title 5, United States Co…](https://policyrisk.com/legislation/119-hr-4582)
- [119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025](https://policyrisk.com/legislation/119-hr-3514)
- [119-hr-979: AM Radio for Every Vehicle Act of 2025](https://policyrisk.com/legislation/119-hr-979)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-1620 (as of 2026-04-21).